nodes	percent_of_prediction	percent_of_DWPC	metapath
Nedocromil—HSP90AA1—pons—germ cell cancer	0.0504	0.0862	CbGeAlD
Nedocromil—HSP90AA1—NOD pathway—NLRP7—germ cell cancer	0.0489	0.165	CbGpPWpGaD
Nedocromil—HSP90AA1—pineal body—germ cell cancer	0.036	0.0615	CbGeAlD
Nedocromil—PTGDR—trigeminal ganglion—germ cell cancer	0.033	0.0564	CbGeAlD
Nedocromil—HSP90AA1—ganglion—germ cell cancer	0.0258	0.0441	CbGeAlD
Nedocromil—HSP90AA1—endothelium—germ cell cancer	0.0223	0.038	CbGeAlD
Nedocromil—HSP90AA1—blood vessel—germ cell cancer	0.0205	0.0351	CbGeAlD
Nedocromil—FPR1—bone marrow—germ cell cancer	0.0193	0.033	CbGeAlD
Nedocromil—PTGDR—adrenal gland—germ cell cancer	0.0189	0.0322	CbGeAlD
Nedocromil—HSP90AA1—Regulation of Androgen receptor activity—NR0B1—germ cell cancer	0.0183	0.0618	CbGpPWpGaD
Nedocromil—PTGDR—bone marrow—germ cell cancer	0.0183	0.0312	CbGeAlD
Nedocromil—FPR1—endocrine gland—germ cell cancer	0.0173	0.0296	CbGeAlD
Nedocromil—FPR1—head—germ cell cancer	0.0171	0.0292	CbGeAlD
Nedocromil—PTGDR—head—germ cell cancer	0.0162	0.0276	CbGeAlD
Nedocromil—HSP90AA1—neck—germ cell cancer	0.0147	0.0251	CbGeAlD
Nedocromil—CYSLTR1—trigeminal ganglion—germ cell cancer	0.0146	0.025	CbGeAlD
Nedocromil—HSP90AA1—trigeminal ganglion—germ cell cancer	0.0127	0.0217	CbGeAlD
Nedocromil—HSP90AA1—embryo—germ cell cancer	0.0123	0.0209	CbGeAlD
Nedocromil—PTGDR—brain—germ cell cancer	0.0117	0.02	CbGeAlD
Nedocromil—PTGDR—lymph node—germ cell cancer	0.0113	0.0193	CbGeAlD
Nedocromil—HSP90AA1—brainstem—germ cell cancer	0.0112	0.0192	CbGeAlD
Nedocromil—HSP90AA1—eye—germ cell cancer	0.0109	0.0187	CbGeAlD
Nedocromil—HSP90AA1—retina—germ cell cancer	0.0108	0.0185	CbGeAlD
Nedocromil—HSP90AA1—telencephalon—germ cell cancer	0.00996	0.017	CbGeAlD
Nedocromil—CYSLTR1—uterus—germ cell cancer	0.00952	0.0163	CbGeAlD
Nedocromil—HSP90AA1—skin of body—germ cell cancer	0.00951	0.0162	CbGeAlD
Nedocromil—HSP90AA1—decidua—germ cell cancer	0.00944	0.0161	CbGeAlD
Nedocromil—CYSLTR1—adrenal gland—germ cell cancer	0.00835	0.0143	CbGeAlD
Nedocromil—HSP90AA1—gonad—germ cell cancer	0.00832	0.0142	CbGeAlD
Nedocromil—HSP90AA1—uterus—germ cell cancer	0.00826	0.0141	CbGeAlD
Nedocromil—HSP90AA1—pituitary gland—germ cell cancer	0.00811	0.0139	CbGeAlD
Nedocromil—CYSLTR1—bone marrow—germ cell cancer	0.00808	0.0138	CbGeAlD
Nedocromil—HSP90AA1—medulla oblongata—germ cell cancer	0.00783	0.0134	CbGeAlD
Nedocromil—HSP90AA1—adrenal gland—germ cell cancer	0.00725	0.0124	CbGeAlD
Nedocromil—CYSLTR1—endocrine gland—germ cell cancer	0.00724	0.0124	CbGeAlD
Nedocromil—HSP90AA1—midbrain—germ cell cancer	0.00716	0.0122	CbGeAlD
Nedocromil—CYSLTR1—head—germ cell cancer	0.00715	0.0122	CbGeAlD
Nedocromil—HSP90AA1—Cellular responses to stress—PHC1—germ cell cancer	0.00711	0.024	CbGpPWpGaD
Nedocromil—HSP90AA1—bone marrow—germ cell cancer	0.00701	0.012	CbGeAlD
Nedocromil—HSP90AA1—spinal cord—germ cell cancer	0.00698	0.0119	CbGeAlD
Nedocromil—FPR1—Peptide ligand-binding receptors—OXT—germ cell cancer	0.00696	0.0235	CbGpPWpGaD
Nedocromil—HSP90AA1—female gonad—germ cell cancer	0.00676	0.0115	CbGeAlD
Nedocromil—PTGDR—G alpha (s) signalling events—AVP—germ cell cancer	0.00648	0.0219	CbGpPWpGaD
Nedocromil—HSP90AA1—endocrine gland—germ cell cancer	0.00628	0.0107	CbGeAlD
Nedocromil—HSP90AA1—head—germ cell cancer	0.0062	0.0106	CbGeAlD
Nedocromil—HSP90AA1—testis—germ cell cancer	0.00599	0.0102	CbGeAlD
Nedocromil—HSP90AA1—cerebellum—germ cell cancer	0.00554	0.00946	CbGeAlD
Nedocromil—CYSLTR2—G alpha (q) signalling events—OXT—germ cell cancer	0.00534	0.018	CbGpPWpGaD
Nedocromil—CYSLTR1—brain—germ cell cancer	0.00518	0.00885	CbGeAlD
Nedocromil—CYSLTR1—lymph node—germ cell cancer	0.00501	0.00855	CbGeAlD
Nedocromil—HSP90AA1—NRF2 pathway—SLC2A3—germ cell cancer	0.00481	0.0162	CbGpPWpGaD
Nedocromil—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—germ cell cancer	0.00478	0.0161	CbGpPWpGaD
Nedocromil—FPR1—Peptide ligand-binding receptors—AVP—germ cell cancer	0.00477	0.0161	CbGpPWpGaD
Nedocromil—FPR1—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	0.00467	0.0158	CbGpPWpGaD
Nedocromil—PTGDR—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	0.00451	0.0152	CbGpPWpGaD
Nedocromil—HSP90AA1—brain—germ cell cancer	0.0045	0.00768	CbGeAlD
Nedocromil—HSP90AA1—lymph node—germ cell cancer	0.00434	0.00742	CbGeAlD
Nedocromil—Photophobia—Vinblastine—germ cell cancer	0.00387	0.0327	CcSEcCtD
Nedocromil—CYSLTR1—G alpha (q) signalling events—OXT—germ cell cancer	0.0037	0.0125	CbGpPWpGaD
Nedocromil—CYSLTR2—G alpha (q) signalling events—AVP—germ cell cancer	0.00366	0.0124	CbGpPWpGaD
Nedocromil—HSP90AA1—Hypoxic and oxygen homeostasis regulation of HIF-1-alpha—TP53—germ cell cancer	0.00358	0.0121	CbGpPWpGaD
Nedocromil—FPR1—GPCR ligand binding—OXT—germ cell cancer	0.00355	0.012	CbGpPWpGaD
Nedocromil—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	0.00354	0.0119	CbGpPWpGaD
Nedocromil—PTGDR—GPCR ligand binding—OXT—germ cell cancer	0.00343	0.0116	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by constitutively active EGFR—HRAS—germ cell cancer	0.00342	0.0116	CbGpPWpGaD
Nedocromil—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—germ cell cancer	0.00331	0.0112	CbGpPWpGaD
Nedocromil—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—germ cell cancer	0.00327	0.0111	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—TDGF1—germ cell cancer	0.00326	0.011	CbGpPWpGaD
Nedocromil—FPR1—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	0.0032	0.0108	CbGpPWpGaD
Nedocromil—PTGDR—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	0.00309	0.0104	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—SALL4—germ cell cancer	0.00277	0.00937	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR ligand binding—OXT—germ cell cancer	0.00269	0.00909	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—NANOG—germ cell cancer	0.00266	0.00898	CbGpPWpGaD
Nedocromil—CYSLTR2—Endothelins—HRAS—germ cell cancer	0.00264	0.0089	CbGpPWpGaD
Nedocromil—Arthritis—Bleomycin—germ cell cancer	0.0026	0.022	CcSEcCtD
Nedocromil—HSP90AA1—Developmental Biology—POU5F1—germ cell cancer	0.00256	0.00864	CbGpPWpGaD
Nedocromil—HSP90AA1—IL2 signaling events mediated by PI3K—MYC—germ cell cancer	0.00256	0.00863	CbGpPWpGaD
Nedocromil—CYSLTR1—G alpha (q) signalling events—AVP—germ cell cancer	0.00254	0.00856	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by ERBB2—FGF4—germ cell cancer	0.00253	0.00855	CbGpPWpGaD
Nedocromil—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	0.00245	0.00828	CbGpPWpGaD
Nedocromil—FPR1—GPCR ligand binding—AVP—germ cell cancer	0.00244	0.00822	CbGpPWpGaD
Nedocromil—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	0.00242	0.00818	CbGpPWpGaD
Nedocromil—PTGDR—GPCR ligand binding—AVP—germ cell cancer	0.00235	0.00794	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—FGF4—germ cell cancer	0.00233	0.00786	CbGpPWpGaD
Nedocromil—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—germ cell cancer	0.00227	0.00766	CbGpPWpGaD
Nedocromil—HSP90AA1—LKB1 signaling events—MYC—germ cell cancer	0.00227	0.00765	CbGpPWpGaD
Nedocromil—HSP90AA1—Aryl Hydrocarbon Receptor—MYC—germ cell cancer	0.00215	0.00725	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by ERBB2—KITLG—germ cell cancer	0.00208	0.00702	CbGpPWpGaD
Nedocromil—Pharyngitis—Vinblastine—germ cell cancer	0.00206	0.0174	CcSEcCtD
Nedocromil—Nasal congestion—Cisplatin—germ cell cancer	0.00205	0.0173	CcSEcCtD
Nedocromil—HSP90AA1—Developmental Biology—KLF4—germ cell cancer	0.00202	0.00681	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—OXT—germ cell cancer	0.00201	0.00678	CbGpPWpGaD
Nedocromil—Pneumonia—Bleomycin—germ cell cancer	0.00196	0.0165	CcSEcCtD
Nedocromil—PTGDR—GPCR downstream signaling—OXT—germ cell cancer	0.00194	0.00655	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—KITLG—germ cell cancer	0.00191	0.00646	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR ligand binding—OXT—germ cell cancer	0.00187	0.0063	CbGpPWpGaD
Nedocromil—HSP90AA1—LKB1 signaling events—TP53—germ cell cancer	0.00186	0.00629	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR ligand binding—AVP—germ cell cancer	0.00185	0.00623	CbGpPWpGaD
Nedocromil—Pneumonia—Dactinomycin—germ cell cancer	0.00183	0.0154	CcSEcCtD
Nedocromil—CYSLTR1—Endothelins—HRAS—germ cell cancer	0.00183	0.00617	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—OXT—germ cell cancer	0.00182	0.00616	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—OXT—germ cell cancer	0.00176	0.00595	CbGpPWpGaD
Nedocromil—HSP90AA1—Class I PI3K signaling events—HRAS—germ cell cancer	0.00172	0.0058	CbGpPWpGaD
Nedocromil—HSP90AA1—Aryl Hydrocarbon Receptor—HRAS—germ cell cancer	0.00169	0.0057	CbGpPWpGaD
Nedocromil—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	0.00168	0.00567	CbGpPWpGaD
Nedocromil—Pneumonia—Ifosfamide—germ cell cancer	0.00168	0.0141	CcSEcCtD
Nedocromil—Pharyngitis—Dactinomycin—germ cell cancer	0.00162	0.0137	CcSEcCtD
Nedocromil—Conjunctivitis—Ifosfamide—germ cell cancer	0.00162	0.0137	CcSEcCtD
Nedocromil—Leukopenia—Vinblastine—germ cell cancer	0.00161	0.0136	CcSEcCtD
Nedocromil—HSP90AA1—Regulation of Telomerase—MYC—germ cell cancer	0.00157	0.0053	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by ERBB2—FGFR3—germ cell cancer	0.00155	0.00522	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—H2AFZ—germ cell cancer	0.00154	0.00519	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—OXT—germ cell cancer	0.00152	0.00514	CbGpPWpGaD
Nedocromil—Visual impairment—Ifosfamide—germ cell cancer	0.00144	0.0122	CcSEcCtD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—FGFR3—germ cell cancer	0.00142	0.0048	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—SOX2—germ cell cancer	0.00142	0.0048	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by ERBB2—KIT—germ cell cancer	0.00142	0.00479	CbGpPWpGaD
Nedocromil—Conjunctivitis—Cisplatin—germ cell cancer	0.0014	0.0118	CcSEcCtD
Nedocromil—HSP90AA1—Validated targets of C-MYC transcriptional activation—MYC—germ cell cancer	0.00139	0.00471	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—OXT—germ cell cancer	0.00138	0.00467	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—AVP—germ cell cancer	0.00138	0.00465	CbGpPWpGaD
Nedocromil—Leukopenia—Bleomycin—germ cell cancer	0.00136	0.0115	CcSEcCtD
Nedocromil—PTGDR—GPCR downstream signaling—AVP—germ cell cancer	0.00133	0.00449	CbGpPWpGaD
Nedocromil—Cough—Bleomycin—germ cell cancer	0.00133	0.0112	CcSEcCtD
Nedocromil—Pneumonia—Etoposide—germ cell cancer	0.00132	0.0112	CcSEcCtD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—KIT—germ cell cancer	0.00131	0.00441	CbGpPWpGaD
Nedocromil—Chest pain—Bleomycin—germ cell cancer	0.0013	0.0109	CcSEcCtD
Nedocromil—CYSLTR1—GPCR ligand binding—AVP—germ cell cancer	0.00128	0.00432	CbGpPWpGaD
Nedocromil—Leukopenia—Dactinomycin—germ cell cancer	0.00127	0.0107	CcSEcCtD
Nedocromil—Pain—Vinblastine—germ cell cancer	0.00126	0.0106	CcSEcCtD
Nedocromil—FPR1—Signaling by GPCR—AVP—germ cell cancer	0.00125	0.00422	CbGpPWpGaD
Nedocromil—Anaphylactic shock—Bleomycin—germ cell cancer	0.00124	0.0105	CcSEcCtD
Nedocromil—Visual impairment—Cisplatin—germ cell cancer	0.00124	0.0105	CcSEcCtD
Nedocromil—PTGDR—Signaling by GPCR—AVP—germ cell cancer	0.00121	0.00408	CbGpPWpGaD
Nedocromil—Gastrointestinal pain—Vinblastine—germ cell cancer	0.0012	0.0102	CcSEcCtD
Nedocromil—Leukopenia—Ifosfamide—germ cell cancer	0.00116	0.00984	CcSEcCtD
Nedocromil—Abdominal pain—Vinblastine—germ cell cancer	0.00116	0.00982	CcSEcCtD
Nedocromil—HSP90AA1—Validated targets of C-MYC transcriptional activation—TP53—germ cell cancer	0.00114	0.00386	CbGpPWpGaD
Nedocromil—Cough—Ifosfamide—germ cell cancer	0.00114	0.00959	CcSEcCtD
Nedocromil—HSP90AA1—Glucocorticoid receptor regulatory network—TP53—germ cell cancer	0.00111	0.00375	CbGpPWpGaD
Nedocromil—Dyspnoea—Bleomycin—germ cell cancer	0.00111	0.00936	CcSEcCtD
Nedocromil—Chest pain—Ifosfamide—germ cell cancer	0.00111	0.00936	CcSEcCtD
Nedocromil—Hypersensitivity—Vinblastine—germ cell cancer	0.00108	0.00915	CcSEcCtD
Nedocromil—FPR1—Signaling Pathways—OXT—germ cell cancer	0.00108	0.00364	CbGpPWpGaD
Nedocromil—Pain—Bleomycin—germ cell cancer	0.00106	0.00897	CcSEcCtD
Nedocromil—Anaphylactic shock—Ifosfamide—germ cell cancer	0.00106	0.00897	CcSEcCtD
Nedocromil—Asthenia—Vinblastine—germ cell cancer	0.00106	0.00891	CcSEcCtD
Nedocromil—CYSLTR1—GPCR downstream signaling—OXT—germ cell cancer	0.00106	0.00356	CbGpPWpGaD
Nedocromil—Tremor—Cisplatin—germ cell cancer	0.00105	0.00888	CcSEcCtD
Nedocromil—CYSLTR2—GPCR downstream signaling—AVP—germ cell cancer	0.00104	0.00352	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—OXT—germ cell cancer	0.00104	0.00351	CbGpPWpGaD
Nedocromil—Diarrhoea—Vinblastine—germ cell cancer	0.00101	0.0085	CcSEcCtD
Nedocromil—Dysgeusia—Etoposide—germ cell cancer	0.00101	0.0085	CcSEcCtD
Nedocromil—Leukopenia—Cisplatin—germ cell cancer	0.001	0.00848	CcSEcCtD
Nedocromil—Fatigue—Dactinomycin—germ cell cancer	0.000999	0.00844	CcSEcCtD
Nedocromil—Pain—Dactinomycin—germ cell cancer	0.000991	0.00837	CcSEcCtD
Nedocromil—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—germ cell cancer	0.000988	0.00333	CbGpPWpGaD
Nedocromil—Urticaria—Bleomycin—germ cell cancer	0.000987	0.00834	CcSEcCtD
Nedocromil—Body temperature increased—Bleomycin—germ cell cancer	0.000982	0.0083	CcSEcCtD
Nedocromil—Dizziness—Vinblastine—germ cell cancer	0.000973	0.00822	CcSEcCtD
Nedocromil—HSP90AA1—TNF alpha Signaling Pathway—HRAS—germ cell cancer	0.000969	0.00327	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—H2AFZ—germ cell cancer	0.000964	0.00325	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—OXT—germ cell cancer	0.000958	0.00323	CbGpPWpGaD
Nedocromil—HSP90AA1—EPH-Ephrin signaling—HRAS—germ cell cancer	0.000953	0.00322	CbGpPWpGaD
Nedocromil—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000948	0.008	CcSEcCtD
Nedocromil—CYSLTR2—Signaling by GPCR—AVP—germ cell cancer	0.000947	0.0032	CbGpPWpGaD
Nedocromil—Dyspnoea—Ifosfamide—germ cell cancer	0.000947	0.008	CcSEcCtD
Nedocromil—Vomiting—Vinblastine—germ cell cancer	0.000936	0.0079	CcSEcCtD
Nedocromil—Headache—Vinblastine—germ cell cancer	0.000922	0.00778	CcSEcCtD
Nedocromil—HSP90AA1—Innate Immune System—FGF4—germ cell cancer	0.000921	0.00311	CbGpPWpGaD
Nedocromil—Leukopenia—Etoposide—germ cell cancer	0.00092	0.00777	CcSEcCtD
Nedocromil—FPR1—Signaling Pathways—FGF4—germ cell cancer	0.00092	0.0031	CbGpPWpGaD
Nedocromil—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000917	0.00774	CcSEcCtD
Nedocromil—Body temperature increased—Dactinomycin—germ cell cancer	0.000916	0.00774	CcSEcCtD
Nedocromil—Abdominal pain—Dactinomycin—germ cell cancer	0.000916	0.00774	CcSEcCtD
Nedocromil—Fatigue—Ifosfamide—germ cell cancer	0.000916	0.00773	CcSEcCtD
Nedocromil—Anaphylactic shock—Cisplatin—germ cell cancer	0.000916	0.00773	CcSEcCtD
Nedocromil—Hypersensitivity—Bleomycin—germ cell cancer	0.000916	0.00773	CcSEcCtD
Nedocromil—Pain—Ifosfamide—germ cell cancer	0.000908	0.00767	CcSEcCtD
Nedocromil—Cough—Etoposide—germ cell cancer	0.000897	0.00757	CcSEcCtD
Nedocromil—Asthenia—Bleomycin—germ cell cancer	0.000892	0.00753	CcSEcCtD
Nedocromil—PTGDR—Signaling Pathways—FGF4—germ cell cancer	0.000888	0.003	CbGpPWpGaD
Nedocromil—Chest pain—Etoposide—germ cell cancer	0.000875	0.00739	CcSEcCtD
Nedocromil—Eosinophilia—Methotrexate—germ cell cancer	0.000875	0.00739	CcSEcCtD
Nedocromil—Nausea—Vinblastine—germ cell cancer	0.000874	0.00738	CcSEcCtD
Nedocromil—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000869	0.00733	CcSEcCtD
Nedocromil—HSP90AA1—Disease—SLC2A3—germ cell cancer	0.000862	0.00291	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—H2AFZ—germ cell cancer	0.000862	0.00291	CbGpPWpGaD
Nedocromil—HSP90AA1—VEGFA-VEGFR2 Pathway—HRAS—germ cell cancer	0.000859	0.0029	CbGpPWpGaD
Nedocromil—Hypersensitivity—Dactinomycin—germ cell cancer	0.000854	0.00721	CcSEcCtD
Nedocromil—HSP90AA1—Immune System—PVRL2—germ cell cancer	0.000849	0.00287	CbGpPWpGaD
Nedocromil—Urticaria—Ifosfamide—germ cell cancer	0.000844	0.00712	CcSEcCtD
Nedocromil—Abdominal pain—Ifosfamide—germ cell cancer	0.00084	0.00709	CcSEcCtD
Nedocromil—Body temperature increased—Ifosfamide—germ cell cancer	0.00084	0.00709	CcSEcCtD
Nedocromil—Anaphylactic shock—Etoposide—germ cell cancer	0.000839	0.00708	CcSEcCtD
Nedocromil—Asthenia—Dactinomycin—germ cell cancer	0.000832	0.00702	CcSEcCtD
Nedocromil—FPR1—Signaling Pathways—H2AFZ—germ cell cancer	0.000821	0.00277	CbGpPWpGaD
Nedocromil—Upper respiratory tract infection—Methotrexate—germ cell cancer	0.000821	0.00693	CcSEcCtD
Nedocromil—CYSLTR2—Signaling Pathways—OXT—germ cell cancer	0.000817	0.00276	CbGpPWpGaD
Nedocromil—Dyspnoea—Cisplatin—germ cell cancer	0.000816	0.00689	CcSEcCtD
Nedocromil—HSP90AA1—Signaling by VEGF—HRAS—germ cell cancer	0.000811	0.00274	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—H2AFZ—germ cell cancer	0.000793	0.00268	CbGpPWpGaD
Nedocromil—Diarrhoea—Dactinomycin—germ cell cancer	0.000793	0.0067	CcSEcCtD
Nedocromil—Pneumonia—Methotrexate—germ cell cancer	0.000792	0.00669	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000791	0.00668	CcSEcCtD
Nedocromil—Vomiting—Bleomycin—germ cell cancer	0.00079	0.00667	CcSEcCtD
Nedocromil—Rash—Bleomycin—germ cell cancer	0.000784	0.00662	CcSEcCtD
Nedocromil—Pain—Cisplatin—germ cell cancer	0.000783	0.00661	CcSEcCtD
Nedocromil—Dermatitis—Bleomycin—germ cell cancer	0.000783	0.00661	CcSEcCtD
Nedocromil—Hypersensitivity—Ifosfamide—germ cell cancer	0.000783	0.00661	CcSEcCtD
Nedocromil—Conjunctivitis—Methotrexate—germ cell cancer	0.000766	0.00647	CcSEcCtD
Nedocromil—Asthenia—Ifosfamide—germ cell cancer	0.000762	0.00643	CcSEcCtD
Nedocromil—HSP90AA1—Innate Immune System—KITLG—germ cell cancer	0.000756	0.00255	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—KITLG—germ cell cancer	0.000756	0.00255	CbGpPWpGaD
Nedocromil—Dyspnoea—Etoposide—germ cell cancer	0.000748	0.00632	CcSEcCtD
Nedocromil—FPR1—Signaling Pathways—AVP—germ cell cancer	0.000738	0.00249	CbGpPWpGaD
Nedocromil—Nausea—Bleomycin—germ cell cancer	0.000738	0.00623	CcSEcCtD
Nedocromil—Vomiting—Dactinomycin—germ cell cancer	0.000737	0.00622	CcSEcCtD
Nedocromil—Rash—Dactinomycin—germ cell cancer	0.000731	0.00617	CcSEcCtD
Nedocromil—PTGDR—Signaling Pathways—KITLG—germ cell cancer	0.00073	0.00246	CbGpPWpGaD
Nedocromil—Diarrhoea—Ifosfamide—germ cell cancer	0.000727	0.00614	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000724	0.00612	CcSEcCtD
Nedocromil—Body temperature increased—Cisplatin—germ cell cancer	0.000724	0.00611	CcSEcCtD
Nedocromil—Fatigue—Etoposide—germ cell cancer	0.000723	0.00611	CcSEcCtD
Nedocromil—CYSLTR1—GPCR downstream signaling—AVP—germ cell cancer	0.000723	0.00244	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—SLC2A3—germ cell cancer	0.000722	0.00244	CbGpPWpGaD
Nedocromil—Pain—Etoposide—germ cell cancer	0.000717	0.00606	CcSEcCtD
Nedocromil—PTGDR—Signaling Pathways—AVP—germ cell cancer	0.000713	0.00241	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—SLC22A3—germ cell cancer	0.000711	0.0024	CbGpPWpGaD
Nedocromil—Dizziness—Ifosfamide—germ cell cancer	0.000702	0.00593	CcSEcCtD
Nedocromil—Pharyngitis—Methotrexate—germ cell cancer	0.000702	0.00593	CcSEcCtD
Nedocromil—CYSLTR2—Signaling Pathways—FGF4—germ cell cancer	0.000697	0.00235	CbGpPWpGaD
Nedocromil—Nausea—Dactinomycin—germ cell cancer	0.000688	0.00581	CcSEcCtD
Nedocromil—Gastrointestinal pain—Etoposide—germ cell cancer	0.000686	0.00579	CcSEcCtD
Nedocromil—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—germ cell cancer	0.000685	0.00231	CbGpPWpGaD
Nedocromil—Visual impairment—Methotrexate—germ cell cancer	0.000682	0.00576	CcSEcCtD
Nedocromil—Vomiting—Ifosfamide—germ cell cancer	0.000675	0.0057	CcSEcCtD
Nedocromil—Hypersensitivity—Cisplatin—germ cell cancer	0.000675	0.0057	CcSEcCtD
Nedocromil—Rash—Ifosfamide—germ cell cancer	0.00067	0.00565	CcSEcCtD
Nedocromil—Dermatitis—Ifosfamide—germ cell cancer	0.000669	0.00565	CcSEcCtD
Nedocromil—Urticaria—Etoposide—germ cell cancer	0.000666	0.00563	CcSEcCtD
Nedocromil—Abdominal pain—Etoposide—germ cell cancer	0.000663	0.0056	CcSEcCtD
Nedocromil—Body temperature increased—Etoposide—germ cell cancer	0.000663	0.0056	CcSEcCtD
Nedocromil—Asthenia—Cisplatin—germ cell cancer	0.000657	0.00555	CcSEcCtD
Nedocromil—CYSLTR1—Signaling by GPCR—AVP—germ cell cancer	0.000657	0.00222	CbGpPWpGaD
Nedocromil—Nausea—Ifosfamide—germ cell cancer	0.000631	0.00533	CcSEcCtD
Nedocromil—Diarrhoea—Cisplatin—germ cell cancer	0.000627	0.00529	CcSEcCtD
Nedocromil—CYSLTR2—Signaling Pathways—H2AFZ—germ cell cancer	0.000622	0.0021	CbGpPWpGaD
Nedocromil—Hypersensitivity—Etoposide—germ cell cancer	0.000618	0.00522	CcSEcCtD
Nedocromil—HSP90AA1—Signaling by ERBB2—HRAS—germ cell cancer	0.000613	0.00207	CbGpPWpGaD
Nedocromil—Dysgeusia—Methotrexate—germ cell cancer	0.000603	0.00509	CcSEcCtD
Nedocromil—Asthenia—Etoposide—germ cell cancer	0.000602	0.00508	CcSEcCtD
Nedocromil—Vomiting—Cisplatin—germ cell cancer	0.000582	0.00492	CcSEcCtD
Nedocromil—HSP90AA1—Metabolism—CRABP1—germ cell cancer	0.00058	0.00196	CbGpPWpGaD
Nedocromil—Rash—Cisplatin—germ cell cancer	0.000577	0.00487	CcSEcCtD
Nedocromil—Dermatitis—Cisplatin—germ cell cancer	0.000577	0.00487	CcSEcCtD
Nedocromil—Diarrhoea—Etoposide—germ cell cancer	0.000574	0.00485	CcSEcCtD
Nedocromil—CYSLTR2—Signaling Pathways—KITLG—germ cell cancer	0.000573	0.00193	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—OXT—germ cell cancer	0.000566	0.00191	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—HRAS—germ cell cancer	0.000564	0.0019	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—FGFR3—germ cell cancer	0.000562	0.0019	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—FGFR3—germ cell cancer	0.000562	0.0019	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—AVP—germ cell cancer	0.00056	0.00189	CbGpPWpGaD
Nedocromil—Dizziness—Etoposide—germ cell cancer	0.000555	0.00468	CcSEcCtD
Nedocromil—Leukopenia—Methotrexate—germ cell cancer	0.000551	0.00465	CcSEcCtD
Nedocromil—Nausea—Cisplatin—germ cell cancer	0.000544	0.00459	CcSEcCtD
Nedocromil—PTGDR—Signaling Pathways—FGFR3—germ cell cancer	0.000542	0.00183	CbGpPWpGaD
Nedocromil—Cough—Methotrexate—germ cell cancer	0.000537	0.00454	CcSEcCtD
Nedocromil—HSP90AA1—Immune System—FGF4—germ cell cancer	0.000536	0.00181	CbGpPWpGaD
Nedocromil—Vomiting—Etoposide—germ cell cancer	0.000533	0.0045	CcSEcCtD
Nedocromil—Rash—Etoposide—germ cell cancer	0.000529	0.00447	CcSEcCtD
Nedocromil—Dermatitis—Etoposide—germ cell cancer	0.000528	0.00446	CcSEcCtD
Nedocromil—Headache—Etoposide—germ cell cancer	0.000526	0.00444	CcSEcCtD
Nedocromil—Chest pain—Methotrexate—germ cell cancer	0.000524	0.00443	CcSEcCtD
Nedocromil—HSP90AA1—Innate Immune System—KIT—germ cell cancer	0.000516	0.00174	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—KIT—germ cell cancer	0.000516	0.00174	CbGpPWpGaD
Nedocromil—Anaphylactic shock—Methotrexate—germ cell cancer	0.000502	0.00424	CcSEcCtD
Nedocromil—Nausea—Etoposide—germ cell cancer	0.000498	0.00421	CcSEcCtD
Nedocromil—PTGDR—Signaling Pathways—KIT—germ cell cancer	0.000498	0.00168	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—FGF4—germ cell cancer	0.000495	0.00167	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—FGF4—germ cell cancer	0.000483	0.00163	CbGpPWpGaD
Nedocromil—Dyspnoea—Methotrexate—germ cell cancer	0.000448	0.00378	CcSEcCtD
Nedocromil—Dyspepsia—Methotrexate—germ cell cancer	0.000442	0.00373	CcSEcCtD
Nedocromil—HSP90AA1—Disease—H2AFZ—germ cell cancer	0.000442	0.00149	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—KITLG—germ cell cancer	0.000441	0.00149	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—TP53—germ cell cancer	0.000436	0.00147	CbGpPWpGaD
Nedocromil—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000434	0.00366	CcSEcCtD
Nedocromil—Fatigue—Methotrexate—germ cell cancer	0.000433	0.00366	CcSEcCtD
Nedocromil—CYSLTR1—Signaling Pathways—H2AFZ—germ cell cancer	0.000431	0.00146	CbGpPWpGaD
Nedocromil—Pain—Methotrexate—germ cell cancer	0.00043	0.00363	CcSEcCtD
Nedocromil—CYSLTR2—Signaling Pathways—FGFR3—germ cell cancer	0.000426	0.00144	CbGpPWpGaD
Nedocromil—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000411	0.00347	CcSEcCtD
Nedocromil—HSP90AA1—Disease—KITLG—germ cell cancer	0.000407	0.00137	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—OXT—germ cell cancer	0.000406	0.00137	CbGpPWpGaD
Nedocromil—Urticaria—Methotrexate—germ cell cancer	0.000399	0.00337	CcSEcCtD
Nedocromil—Abdominal pain—Methotrexate—germ cell cancer	0.000397	0.00335	CcSEcCtD
Nedocromil—Body temperature increased—Methotrexate—germ cell cancer	0.000397	0.00335	CcSEcCtD
Nedocromil—CYSLTR1—Signaling Pathways—KITLG—germ cell cancer	0.000397	0.00134	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—KIT—germ cell cancer	0.000391	0.00132	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—AVP—germ cell cancer	0.000388	0.00131	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—HRAS—germ cell cancer	0.000377	0.00127	CbGpPWpGaD
Nedocromil—Hypersensitivity—Methotrexate—germ cell cancer	0.00037	0.00313	CcSEcCtD
Nedocromil—PTGDR—Signaling by GPCR—HRAS—germ cell cancer	0.000364	0.00123	CbGpPWpGaD
Nedocromil—Asthenia—Methotrexate—germ cell cancer	0.000361	0.00304	CcSEcCtD
Nedocromil—HSP90AA1—Axon guidance—HRAS—germ cell cancer	0.000354	0.00119	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—FGF4—germ cell cancer	0.000347	0.00117	CbGpPWpGaD
Nedocromil—Diarrhoea—Methotrexate—germ cell cancer	0.000344	0.0029	CcSEcCtD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—MYC—germ cell cancer	0.000333	0.00112	CbGpPWpGaD
Nedocromil—Dizziness—Methotrexate—germ cell cancer	0.000332	0.00281	CcSEcCtD
Nedocromil—HSP90AA1—Immune System—FGFR3—germ cell cancer	0.000327	0.00111	CbGpPWpGaD
Nedocromil—Vomiting—Methotrexate—germ cell cancer	0.000319	0.0027	CcSEcCtD
Nedocromil—Rash—Methotrexate—germ cell cancer	0.000317	0.00268	CcSEcCtD
Nedocromil—Dermatitis—Methotrexate—germ cell cancer	0.000317	0.00267	CcSEcCtD
Nedocromil—Headache—Methotrexate—germ cell cancer	0.000315	0.00266	CcSEcCtD
Nedocromil—HSP90AA1—Signaling Pathways—H2AFZ—germ cell cancer	0.00031	0.00105	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—FGFR3—germ cell cancer	0.000302	0.00102	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—KIT—germ cell cancer	0.000301	0.00101	CbGpPWpGaD
Nedocromil—Nausea—Methotrexate—germ cell cancer	0.000298	0.00252	CcSEcCtD
Nedocromil—HSP90AA1—Cell Cycle—MYC—germ cell cancer	0.000298	0.00101	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—FGFR3—germ cell cancer	0.000295	0.000996	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—HRAS—germ cell cancer	0.000286	0.000965	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—KITLG—germ cell cancer	0.000285	0.000962	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—MYC—germ cell cancer	0.000284	0.000958	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—AVP—germ cell cancer	0.000278	0.00094	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—KIT—germ cell cancer	0.000278	0.000937	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—MYC—germ cell cancer	0.000274	0.000925	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—KIT—germ cell cancer	0.000271	0.000914	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—HRAS—germ cell cancer	0.000253	0.000853	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—TP53—germ cell cancer	0.000245	0.000825	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—TP53—germ cell cancer	0.000233	0.000786	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—TP53—germ cell cancer	0.000225	0.000759	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—HRAS—germ cell cancer	0.000223	0.000753	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—HRAS—germ cell cancer	0.000223	0.000752	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—HRAS—germ cell cancer	0.000215	0.000726	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—MYC—germ cell cancer	0.000215	0.000726	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—FGFR3—germ cell cancer	0.000212	0.000715	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—HRAS—germ cell cancer	0.000198	0.000669	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—KIT—germ cell cancer	0.000194	0.000656	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—TP53—germ cell cancer	0.000177	0.000596	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—HRAS—germ cell cancer	0.000169	0.00057	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—MYC—germ cell cancer	0.000153	0.000516	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—MYC—germ cell cancer	0.000149	0.000503	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—HRAS—germ cell cancer	0.00013	0.000439	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—TP53—germ cell cancer	0.000122	0.000413	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—HRAS—germ cell cancer	0.00012	0.000405	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—HRAS—germ cell cancer	0.000117	0.000395	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—MYC—germ cell cancer	0.000107	0.000361	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—TP53—germ cell cancer	8.78e-05	0.000297	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—HRAS—germ cell cancer	8.4e-05	0.000284	CbGpPWpGaD
